Premier Path Wealth Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Hold |
20,265
| – | – | 0.02% | 384 |
|
|
2025
Q1 | $71.7K | Buy |
+20,265
| New | +$71.7K | 0.01% | 372 |
|
|
2024
Q4 | – | Sell |
-20,265
| Closed | -$65.7K | – | 370 |
|
|
2024
Q3 | $65.7K | Buy |
+20,265
| New | +$65.7K | 0.01% | 364 |
|
|
2024
Q2 | – | Sell |
-20,265
| Closed | -$57.6K | – | 369 |
|
|
2024
Q1 | $57.6K | Hold |
20,265
| – | – | 0.01% | 343 |
|
|
2023
Q4 | $298K | Buy |
+20,265
| New | +$298K | 0.07% | 261 |
|